The National Institute for Health and Care Excellence (Nice) is concerned about the number of people regaining weight after ...

Weston's downgrade still values Novo Nordisk stock above its current share price of $47 and change, however. Moreover, Novo ...

Hims & Hers Health stock fell as much as 5% early Tuesday after the company reported revenue late Monday that fell shy of ...

FAT jabs are not a “quick fix” and patients must be followed up for at least a year to keep the weight off, the NHS watchdog ...

When it comes to weight loss, there are a number of tried and true lifestyle changes you can make to help you along the way.

Shares of telehealth firm Hims & Hers fell as much as 5% on Tuesday after the company reported weaker-than-expected second-quarter revenue, hurt by a loss of subscribers in its weight-loss treatment ...

Eli Lilly and Novo Nordisk are actively exploring other medical uses for their GLP-1 drugs, and have already seen some ...

This potential loss of strength when taking Ozempic could be a particular concern for adults over the age of 60 who are at a higher risk of muscle loss and reduced mobility.

People using weight loss medication have been told it's not a "quick fix" with many at risk of regaining their lost weight.

People using weight loss medication have been warned it is not a "quick fix" with many at risk of regaining their lost weight ...

Experts say NHS patients should be monitored for at least a year after treatment ends, with tailored support provided if ...

A study published in Cell Metabolism looks at the effects of semaglutide on skeletal muscle mass in mice. Prof Lora Heisler, Director of Research, Rowett Institute, University of Aberdeen, Rowett ...